Previous Article | Next Article 
Infect Immun, May 1998, p. 2065-2071, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Clearance of Borrelia burgdorferi May
Not Be Required for Resistance to Experimental Lyme Arthritis
Charles R.
Brown and
Steven L.
Reiner*
Department of Medicine, Gwen Knapp Center for
Lupus and Immunology Research, and Committee on Immunology,
University of Chicago, Chicago, Illinois 60637
Received 25 August 1997/Returned for modification 21 October
1997/Accepted 16 February 1998
 |
ABSTRACT |
Infection of inbred mouse strains with Borrelia
burgdorferi results in the development of experimental Lyme
arthritis. The degree of arthritic pathology has been suggested to
correlate with the level of spirochete burden within tissues. To
investigate this further, we infected resistant DBA/2 (DBA) and
susceptible C3H/HeJ (C3H) mice in the hind footpads and monitored
arthritis development for 21 days. To quantitate levels of spirochetes
within tissues, we created a competitive PCR molecule containing
modified ospA and fla gene segments. C3H mice
developed severe arthritis of the tibiotarsal joints, while DBA mice
developed only mild inflammation throughout the experimental period. At
day 21, when the gross size and histologic composition of ankles
revealed significant differences in arthritis between the strains,
there was little difference in levels of spirochete DNA as determined
by competitive PCR. Cultures of ankle tissue at day 21 were also
uniformly positive in both C3H and DBA animals and contained relatively
similar levels of spirochetes. These results indicate that the presence
of spirochetes in the ankles of experimental animals is not sufficient
for arthritis development. Since arthritic and nonarthritic animals can
harbor relatively equal spirochete burdens yet retain their distinct phenotypic outcomes, an aberrant or overly exuberant immune response may be an additional requirement for pathology in arthritis-prone mice.
 |
INTRODUCTION |
Lyme disease is a multisystemic
illness caused by infection with the spirochete Borrelia
burgdorferi (27). Left untreated, infected individuals
usually develop a recurring arthritis in one or multiple joints and
occasionally carditis or neurologic disease. Antibiotic treatment
results in resolution of disease in most individuals, indicating that
spirochetal presence is needed for the persistence of pathology. In
some individuals, however, arthritis persists despite adequate
antibiotic therapy and an inability to detect spirochetes in inflamed
tissues (26). Individuals having the major
histocompatibility complex class II allele HLA-DR2 or -DR4 appear to be
more likely to develop severe arthritis of longer duration following
Borrelia infection (28). This suggests that the
host immune response is also an important determinant for development
of pathology.
In experimental models, cellular and humoral immune responses to
B. burgdorferi (12, 15, 24), T-helper cell
phenotype (16, 18), and levels of spirochete virulence
(1, 4) influence arthritis development. C3H/HeJ (C3H) mice
develop severe arthritis and BALB/c mice develop mild arthritis upon
intradermal infection with B. burgdorferi
(6). Experimental Lyme arthritis in mice is transient, is
usually most pronounced at 14 to 30 days, and then resolves over the
next 60 days. Several studies have suggested that the development of
arthritis in susceptible mouse strains correlates with higher numbers
of spirochetes in these hosts (7, 21, 29). The presence of
viable spirochetes in the joints is required for arthritis development,
as injection of heat-killed spirochetes or Borrelia antigen
does not result in pathology (5, 17). Mice can remain
chronically infected, however, without developing arthritis
(10). In addition, experimental intervention may result in a
reduction of peak arthritis severity yet cause an increase in
spirochete burden (2). The precise role that spirochete
burden plays in determining disease phenotype, therefore, remains
unclear.
We created a competitive PCR construct containing modified
Borrelia ospA and fla genes. This technique
allowed us to compare the relative presence of Borrelia DNA,
both plasmid and genomic, in murine tissues after standardization to a
single-copy mammalian gene (IL4pr). We found that following
footpad injection of B. burgdorferi, arthritis-susceptible
C3H and arthritis-resistant DBA/2 (DBA) mice contain similar levels of
spirochetes within their ankles during the time of peak arthritis
development. These results indicate that the presence of significant
numbers of spirochetes in ankles of inbred mouse strains is not
sufficient for the development of Lyme arthritis. This suggests that
unique host factors, and not merely microbial presence, are needed for
arthritis development in susceptible strains of mice.
 |
MATERIALS AND METHODS |
Mice and infections.
Female C3H and DBA mice were purchased
from The Jackson Laboratory (Bar Harbor, Maine). All mice were between
4 and 6 weeks of age at the time of infection. B. burgdorferi N40 was kindly provided by Steven Barthold (Yale
University, New Haven, Conn.). Spirochetes were reisolated from severe
combined immunodeficiency mice, passaged twice in
Barbour-Stoenner-Kelly II medium (Sigma Chemical Co., St. Louis, Mo.),
and frozen in aliquots at
80°C. For infections, an aliquot was
thawed, placed in 7 ml of medium, and grown for 5 days at 32°C. Mice
were inoculated in both hind footpads with 106 B. burgdorferi organisms in 50 µl of medium. Tibiotarsal joints were measured weekly with a metric caliper (Ralmike's Tool-A-Rama, South Plainfield, N.J.) through the thickest anteroposterior diameter of the ankle. Blood, heart, spleen, urinary bladder, skin, and ankles
were aseptically collected and cultured at 32°C for 14 days in
Barbour-Stoenner-Kelly II medium. Cultures were scored by placing 10 µl of supernatant on a microscope slide under a cover- slip (22 by 22 mm) and examining 20 high-power fields by dark-field microscopy.
Histology.
Mice were sacrificed 21 days following infection;
the ankles were washed with 70% ethanol, and the skin was removed. The
sample was excised by cutting just above and below the ankle joint and placing it in 10% buffered formalin. After several days, the sample was embedded in paraffin, sectioned, and stained with hematoxylin and
eosin. Arthritis severity scores were determined in a blinded manner
and rated on a scale of 0 to 3 (9). Grade 0 represents no
inflammation, grades 1 and 2 represent mild-to-moderate inflammation, and grade 3 represents severe inflammation.
Construction of BC3 PCR competitor.
The BC3
Borrelia competitive PCR molecule was constructed by
utilizing a strategy similar to that employed by Reiner et al. (23), except that bacterial genomic or plasmid DNA, rather
than mammalian cDNA, was modified. Briefly, genomic and plasmid DNAs were isolated from a B. burgdorferi culture or a mouse
spleen with sodium dodecyl sulfate-Tris lysis buffer (0.1-mg/ml
proteinase K in 200 mM NaCl-20 mM Tris-HCl [pH 8.0]-50 mM
EDTA-0.2% sodium dodecyl sulfate). Segments of the genes of interest
were amplified by PCR (see PCR conditions) using the primer sets listed
below. The amplified products were isolated by gel purification from low-melting-point agarose and ligated into plasmid pGEM11Z(f), which
had been linearized by blunt-end digestion and incubated with dTTP and
Taq polymerase. The individual plasmids containing the three
gene segments of interest were linearized by using unique internal
restriction enzyme sites, and the ends were dephosphorylated. Digestions of genomic DNA were completed by using the same set of
restriction enzymes, and approximately 75 bp of DNA was excised from a
low-melting-point agarose gel. This small random DNA pool was then
ligated into the wild-type fla, ospA, or
IL4pr gene product to create addition mutations. Cloned
colonies were picked after transformation. Once these addition
mutations were made, the fla-containing plasmid was
linearized with EcoRI and SacI. The
ospA and IL4pr modified gene segment inserts were
excised from their plasmids (ospA was excised with
SacI and Xho; IL4pr was excised with
Xho and EcoRI) and ligated as a trimolecular
reaction. The completed competitor plasmid was called pBC3. The
polycompetitor insert was excised from pBC3 with SacI and
NotI for ease of use in PCR. This competitor insert was
called BC3.
DNA extractions.
Tissue samples were collected for PCR
analysis at each time point from both strains of mice. Extraction of
ankles was performed by removing the skin and cutting just above and
below the tibiotarsal joint. All excised ankle samples were
approximately equal in size. Exact measurements were not needed, as the
amount of tissue used in each PCR was equalized later by using the
IL4pr competitor. To extract DNA from ankle tissue, samples
were first digested overnight in 0.5 ml of 1% collagenase at 37°C.
Supernatants were then transferred to new tubes, 0.25 ml of 3× lysis
buffer (see above) was added, and the mixture was incubated at 55°C
for 4 h. Following incubation, debris was pelleted and the
supernatants were transferred to tubes containing 0.8 ml of
isopropanol. Sample DNA was precipitated on ice for 60 min. DNA was
pelleted at 4°C, air dried, and resuspended in 100 µl of Tris-EDTA
buffer.
PCR conditions.
PCR amplification of both wild-type and BC3
gene segments was performed with the following sets of primers:
fla 5' primer GATGATGCTGCTGGTATGGGGGTTTCT plus
fla 3' primer CCTCTGTCTGCGTCTGAATATGTACCG, ospA 5' primer TCTTGAAGGAAGTTTAACTGCTG plus ospA
3' primer CAAGTTTTGTAATTTCAACTGCTGA, and IL4pr 5'
primer GATCAGCTGGGCTAGGATGCGAGA plus IL4pr 3'
primer GGGCCAATCAGCACCTCTCTTCCA. Sample reaction mixtures
contained MgCl2 at 2.5 mM for IL4pr and
ospA reactions and 1.5 mM for fla reactions. For
IL4pr reactions, samples were initially denatured for
60 s, and then the cycling parameters were denaturation at 94°C
for 50 s, annealing at 60°C for 30 s, and extension at
72°C for 50 s for 35 cycles. For ospA and
fla amplification, an initial 60-s denaturation step was
followed by 45 or 47 cycles of denaturation at 94°C for 60 s,
annealing at 60°C for 60 s, and extension at 72°C for 90 s. All samples for a given primer set were spiked with equal amounts of
BC3 to allow comparisons between samples.
Statistics.
Means of ankle diameters were compared by using
the Student t test.
 |
RESULTS |
Development of arthritis in experimental animals.
Mice were
inoculated in the hind footpads, and arthritis development was
monitored for 21 days. Ankle thickness versus time of infection of
resistant DBA and susceptible C3H mice is shown in Fig.
1. At 7 days postinfection, there was
very little difference in gross ankle size between the two experimental
groups. At day 14, however, the ankles of C3H mice were significantly
larger than those of DBA mice (P < 0.01). This
increase in ankle swelling was still continuing in the C3H mice at day
21. Because ankle diameter does not always correlate with arthritis
development (2), ankles of resistant and susceptible animals
were examined histologically for the development of inflammatory cell
infiltrates and changes typical of arthritis. In C3H mice, increasing
ankle size correlated with the development of severe arthritis (Fig. 2). Ankle sections from C3H mice (Fig.
2A) had abundant inflammatory cell infiltrates in the synovia and bursa
(not shown), while the ankles of DBA mice (Fig. 2B) had only mild
inflammatory infiltrates. Other changes typical of arthritis
development, such as pannus formation and thickening of the synovial
lining, were easily seen in the ankle sections of C3H, but not DBA,
mice. Ankle arthritis severity was scored in a blinded manner with
weekly samples (Table 1). There was
little difference in arthritis development between C3H and DBA animals
at day 7 of infection. By day 14, however, ankles of C3H mice were
developing a severe arthritis which was still evident at day 21. During
this time, the ankles of resistant DBA mice were only mildly inflamed.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Measurements of hind tibiotarsal joints of mice infected
with B. burgdorferi. Mice were 4 weeks old at the time of
infection in the hind footpad. Squares represent C3H mice, and circles
represent DBA mice. Error bars represent standard deviations. Asterisks
indicate statistically significant difference (P < 0.01) by the Student t test.
|
|

View larger version (134K):
[in this window]
[in a new window]
|
FIG. 2.
Histopathology of tibiotarsal joints from C3H (A) or DBA
(B) mice infected with B. burgdorferi. Joints were obtained
on day 21 of infection, and paraffin sections were stained with
hematoxylin and eosin. Magnification, ×20.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Isolation of B. burgdorferi from selected
tissues and arthritis development in ankles of DBA and
C3H micea
|
|
Assessment of spirochete loads in ankles.
To assess the
relative levels of spirochetes in tissues of infected
arthritis-resistant and -susceptible mice, three C3H and three DBA mice
were randomly sacrificed on days 7, 14, and 21 of infection and their
ankles were removed for PCR analysis. We constructed a PCR competitor
molecule, BC3, containing addition mutations of the Borrelia
fla and ospA and mammalian IL4pr genes (Fig.
3). Both fla and
ospA were used because of the possibility of unequal target
amplification in tissues (22). The ospA gene is
located on a plasmid (11), while fla is a
single-copy gene located on the Borrelia linear chromosome
(14). In another set of experiments, the levels of
spirochetes in blood, hearts, spleens, urinary bladders, skin (ear
punches), and ankles were assessed by culture to ensure the presence of
live spirochetes within the tissues studied.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Schematic representation of cloning strategy for BC3.
Addition mutation is shown for fla only but is the same for
ospA and IL4pr. Wild-type gene segments (e.g.,
wt-fla) were amplified by PCR and cloned into pGEM plasmids.
These were internally modified by the addition of a random 75-bp DNA
segment (e.g., m-fla). BC3p was created by trimolecular
ligation of the modified gene segments into a single molecule. BC3 is
the linearized trimolecular gene segment cut from the pGEM plasmid.
|
|
The BC3 polycompetitor insert was used to spike samples to enable the
relative assessment of
Borrelia DNA in experimental
samples.
Figure
4 shows a standard curve of
ospA amplification.
Tenfold dilutions of a DNA sample
containing 3 × 10
7 B. burgdorferi
organisms were made, and 5 µl was placed in a
PCR. Each reaction was
spiked with a constant amount (2.5 pg)
of the BC3 competitor. The upper
bands in each lane are the BC3
amplification products, and the lower
bands are the wild-type
DNA PCR products. With decreasing levels of
Borrelia DNA, there
is a decrease in the intensity of the
lower band and a corresponding
increase in the upper BC3 band. At the
10
5 sample dilution, the upper and lower bands are
relatively equal,
enabling an estimation that 2.5 pg of BC3 contains
approximately
1,500 mutated
B. burgdorferi genomic
equivalents. At a higher
cycle number (routinely 45), we were able to
amplify sample concentrations
10- to 100-fold more dilute (or lower)
than this. Levels of tissue
DNA for each sample were equalized by using
the single-copy mammalian
gene for interleukin 4 (
20). For
example, DNA extracted from
ankles harvested 7 days after infection
were placed in PCR mixtures
containing a constant amount of the BC3
competitor. Amounts of
DNA in each sample were then adjusted during
subsequent rounds
of PCR amplification until they all contained similar
ratios of
wild-type to competitor bands. At that point, all samples
contained
the same amount of mammalian DNA, which controlled for
differences
in tissue sample sizes and also for variation in the
efficiency
of DNA extraction. Thus, the ankle samples from C3H and DBA
mice
can be compared to one another with respect to the levels of
ospA or
fla that they harbor.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
Competitive PCR amplification of ospA from
known numbers of Borrelia spirochetes. A 5-µl volume of
BC3 (2.5 pg) was spiked into 5-µl samples of log dilutions of 3 × 107 B. burgdorferi genomic equivalents.
Results are ospA PCR products from 35 cycles of
amplification.
|
|
Figure
5 shows the PCR results for three
C3H and three DBA ankles at each time point. On day 7, two of the C3H
(lanes 1 and
2) and two of the DBA (lanes 5 and 6) mice had high levels
of
amplification of
ospA from their ankles while the other
C3H and
DBA samples contained lower levels of
ospA (Fig.
5A). The chromosomal
target
fla is less abundant than the
plasmid target
ospA. To amplify
fla, more
concentrated samples and higher dilutions of the BC3
competitor were
needed to reach a point where two bands could
be seen. Thus, some lanes
(e.g., Fig.
5A,
fla lane 2) contain
one or two very light
bands. On day 7, there was a high level
of amplification of
fla gene products from the ankles of two DBA
mice (Fig.
5A,
lanes 5 and 6), while the other DBA lane had higher
amplification of
the BC3 competitor than did wild-type
fla. The
ankles of two
C3H mice had amplification of wild-type
fla equal
to or
slightly greater than that of the BC3 competitor (lanes
2 and 3). No
wild-type
fla could be amplified from the remaining
C3H
ankle sample. These results indicate that at day 7, there
are
relatively equal levels of spirochetes in the ankles of resistant
and
susceptible mice following footpad inoculation. The level
of
variability seen in these samples was highly reproducible
(
11a).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Competitive PCR amplification of ospA,
fla, and IL4pr from ankles of C3H and DBA mice
infected 7 (A), 14 (B), or 21 (C) days earlier. Each lane represents
data from an individual mouse. All samples at days 7 and 14 were
diluted 1:10, and samples at day 21 were diluted 1:50. The amount of
BC3 spiked into the samples was 0.25 pg for all samples except that for
day 7 fla, which was 0.025 pg.
|
|
On day 14, the ankle samples from all three C3H mice had high levels of
ospA amplification (Fig.
5B). The ankle samples from
DBA
mice were more heterogeneous, displaying high, intermediate,
and low
levels of
ospA amplification (lanes 4, 5, and 6, respectively).
Amplification of
fla was also more
heterogeneous, with two samples
from C3H mice (lanes 1 and 3) having
high levels and one having
low levels of wild-type DNA. Very little
wild-type
fla DNA could
be amplified from the 14-day DBA
ankle samples, even though faint
wild-type bands could be seen in two
of the three samples (lanes
4 and 5). These results indicate that while
all of the C3H mice
appeared to have significant spirochete burdens in
their ankles
at day 14, some (but not all) of the DBA mice appeared to
contain
fewer spirochetes at that time.
By day 21 of infection, high levels of wild-type
ospA
amplification were present in two samples from the DBA mice (Fig.
5C,
lanes 5 and 6) and high (but slightly less so) levels were present
in
two samples from the C3H samples (lanes 1 and 3). The other
samples
from C3H and DBA mice (lanes 2 and 4) had considerably
less wild-type
ospA gene amplification. All ankle samples from
day 21 had
high levels of wild-type
fla amplification. These results
demonstrate that high levels of spirochetes in the ankles of resistant
mouse strains, as assessed by PCR amplification of either plasmid
or
genomic
Borrelia DNA, do not necessitate the development of
Lyme arthritis. Over the course of the experiment, there was a
fivefold
increase in the numbers of
B. burgdorferi organisms in
the
ankles of both strains of mice. As shown in the legend to
Fig.
5, with
a constant level of BC3 competitor (0.25 pg), the
samples from days 7 and 14 needed to be diluted only 1:10, while
the day 21 samples
required a 1:50 dilution for amplification
of both products. This
allowed us to estimate that the ankles
on day 7 contained about
1.5 × 10
6 spirochetes, which increased to about
9 × 10
6 by day 21 in both strains.
We also examined spirochete loads in ankles and other distant tissues
by culture (Table
1). There were no differences in
spirochete recovery
from ankles of DBA or C3H mice at any of the
time points tested.
Cultures from ankle tissues were uniformly
positive for both resistant
and susceptible mice and contained
similar numbers of spirochetes (data
not shown). Urinary bladder
was the only other tissue with a positive
culture on day 7, with
one of three mice of both strains positive.
There were few differences
in the culture results of distant sites at
days 14 and 21 of infection,
with the notable exception of blood at day
14. All of the cultures
from DBA mice were positive, with high numbers
of spirochetes,
while the cultures from C3H mice were negative.
Spirochetes were
absent from the blood of two of three DBA mice by day
21, with
the remaining positive culture containing fewer spirochetes.
These
results confirm the PCR analysis, demonstrating relatively small
differences in spirochetal burden in the ankles of resistant and
susceptible mouse strains following footpad infection during the
peak
of arthritis development.
 |
DISCUSSION |
The infection of inbred mouse strains with B. burgdorferi recapitulates a portion of the disease spectrum seen
in human Lyme disease. C3H mice develop severe arthritis, while DBA
mice develop only mild arthritis or joint inflammation (6).
The presence of live B. burgdorferi spirochetes is required
for the development of pathology, as repeated injections of heat-killed
spirochetes or whole-B. burgdorferi antigen has no effect in
rats (5), hamsters (17), or mice
(11a). When injected intradermally, susceptible C3H mice are
more permissive than resistant BALB/c mice to B. burgdorferi
growth and dissemination and harbor higher numbers of spirochetes
within their tissues (29). A higher spirochete tissue burden
has been suggested to be the cause of the increased development of
pathology in susceptible animals. However, whether resistant mice
harboring relatively equal numbers of spirochetes in their ankles would
develop pathology equivalent to that of susceptible mice has not been
tested. To investigate this question more fully, we gave footpad
injections of high numbers of B. burgdorferi spirochetes to
resistant and susceptible mouse strains and monitored arthritis
development. To quantify tissue spirochete burden, we created a
competitive PCR construct containing modified Borrelia chromosomal (fla) and plasmid (ospA) gene
segments. This molecule allows direct comparison of the levels of
spirochetes in tissues of different mouse strains. Our data show that
the presence of high numbers of spirochetes within the ankles of
resistant mouse strains does not dictate the development of Lyme
arthritis. With their ankles harboring relatively equal numbers of
spirochetes, DBA mice remain arthritis resistant while C3H mice develop
severe Lyme arthritis. Thus, an inappropriate or overly exuberant
immune response, and not tissue spirochete burden, might contribute to genetic differences in the propensity to develop experimental Lyme
arthritis.
Several studies have suggested a correlation between the development of
Lyme arthritis and high numbers of spirochetes in tissue (7, 21,
29). Using in vitro cultivation of infected tissues, Keane-Myers
and Nickell (16) compared spirochete levels in ankles and
ear punches from BALB/c and C3H mice. The reported differences in
spirochete burden were less than 10-fold between the resistant and
susceptible animals. Using a similar subculturing technique, however,
Anguita et al. (2) found that C3H mice treated with antibody
to interleukin 12 had a decrease in arthritis severity but an increase
in spirochete burden as assessed by ear punches. Those researchers
suggested that both the tissue spirochete burden and the resulting
immune response were likely to play important roles in the pathogenesis
of Lyme arthritis.
Yang et al. (29) used PCR to determine differences in
spirochete burden in tissues of arthritis-resistant BALB/c and
arthritis-susceptible C3H mice. Following intradermal injection of
2 × 105 spirochetes into the shaved backs of
experimental mice, they assayed various tissues at weekly intervals for
the presence of Borrelia DNA. The susceptible C3H animals
had tissues positive for ospA at weeks 1 through 4, whereas
the BALB/c tissues were only positive for ospA at week 3. Hearts, ankles, and bladders were the most heavily infected tissues of
both mouse strains. Quantitation of spirochete loads by two different
methods indicated 10-fold-higher numbers of spirochetes in C3H hearts
and 5-fold-higher numbers of spirochetes in C3H ankles by
ospA analysis than in BALB/c mice. Similar differences were
seen in the detection of fla, but 10 to 20% fewer organisms
were detected than when ospA was analyzed. BALB/c mice also
had better spirochetal clearance from tissues, while tissue loads of
C3H mice remained high. The investigators concluded that pathology
during infection with B. burgdorferi may be correlated with
the presence of greater numbers of organisms in the tissues of
susceptible animals. Our results do not support this conclusion and
show that the presence of high numbers of spirochetes in ankles of
resistant mice does not induce the development of severe Lyme
arthritis. There are, however, several differences between the
experimental protocols used in these two studies that most likely
explain the differences between the conclusions reached. The major
difference is likely to be the site of inoculation. Yang et al.
(29) injected animals intradermally in the back, mimicking
the natural route of infection. However, this requires that the
spirochetes disseminate to reach the target organs, allowing potential
differences in dissemination between resistant and susceptible animals
to influence the level of organisms within each tissue type. It was for
this reason that we chose footpad injection as our inoculation
protocol. This delivers the organisms very near the target site (ankle)
and minimizes the variable of differing rates of dissemination.
The kinetics of dissemination of B. burgdorferi into various
tissues of inbred mouse strains have been studied by several groups
(7, 9, 10). B. burgdorferi spreads quickly from the site of inoculation to almost all tissues within the host. Following intradermal inoculation of C3H mice, blood, spleen, kidney,
bladder, ankle, and heart are all spirochete positive by day 7 and the
ears are positive by day 10 (7). Arthritis-susceptible strains have a more rapid dissemination and higher levels of
spirochetes in most of the tissues studied than do arthritis-resistant
mice (29). Thus, resistant mice may be better able to
sequester Borrelia spirochetes at the site of infection than
are susceptible mice (25). The infection site has been shown
to be an important determinant in the development of pathology (8,
13). It is known that the presence of live spirochetes within
joints is required for arthritis development. The failure of
high-passage strains to disseminate and reach joints has been suggested
to be one possible reason why they are nonpathogenic (19).
Since PCR does not distinguish between dead and live organisms, it is
possible that DBA mice have a more effective mechanism for killing
Borrelia spirochetes in ankle tissue than do C3H mice. Viable spirochetes are needed for arthritis development, and thus, resistant animals would be protected from pathology by this mechanism. This explanation does not seem plausible to us, however, for the following reasons. The relatively stable or increasing levels of
spirochetal DNA in ankle samples indicate that the numbers of B. burgdorferi spirochetes within ankles of resistant mice are being
maintained or even increased over the course of the experiment. In
addition, spirochetal DNA has been reported to be eliminated along with
viable organisms (3). Finally, the increasing numbers of
culture-positive tissues at distant sites (e.g., the heart) over time
indicate that viable organisms are migrating into these sites, which
could not occur if the spirochetes were killed at the site of
inoculation.
This report demonstrates that differences in pathology between
resistant and susceptible mouse strains need not be due solely to
differences in spirochete burden. More rapid dissemination and higher
tissue spirochete burdens would be expected to play a role in arthritis
development following intradermal infection. The current study
demonstrates that when resistant and susceptible mice harbor relatively
equivalent levels of spirochetes in their joints, they can still retain
their distinct disease phenotype. Thus, other host factors besides
degree of microbial clearance are likely to be important for disease
outcome. Identification of these other factors may help elucidate some
of the genetic contributions to inflammatory diseases.
 |
ACKNOWLEDGMENTS |
This work was supported by the Burroughs Wellcome Fund and by the
NIH (AR 44042).
We thank Dan Brown, Kevin Swier, and Joseph Opferman for critical
reading of the manuscript and Jennifer Bird for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Gwen Knapp
Center for Lupus and Immunology Research, University of Chicago, 924 E. 57th St., Chicago, IL 60637. Phone: (773) 702-4730. Fax: (773) 702-1576. E-mail: sreiner{at}midway.uchicago.edu.
Editor: J. M. Mansfield
 |
REFERENCES |
| 1.
|
Anderson, J.,
S. Barthold, and L. Magnarelli.
1990.
Infectious but nonpathogenic isolate of Borrelia burgdorferi.
J. Clin. Microbiol.
28:2693-2699[Abstract/Free Full Text].
|
| 2.
|
Anguita, J.,
D. H. Persing,
M. Rincon,
S. W. Barthold, and E. Fikrig.
1996.
Effect of anti-interleukin 12 treatment on murine Lyme borreliosis.
J. Clin. Invest.
97:1028-1034[Medline].
|
| 3.
|
Armstrong, A. L.,
S. W. Barthold,
D. H. Persing, and D. S. Beck.
1992.
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.
Am. J. Trop. Med. Hyg.
47:249-258.
|
| 4.
|
Barthold, S.,
K. Moody, and D. Beck.
1990.
Susceptibility of laboratory rats to isolates of Borrelia burgdorferi from different geographic areas.
Am. J. Trop. Med. Hyg.
42:596-600.
|
| 5.
|
Barthold, S. W.,
K. D. Moody,
G. A. Terwilliger,
P. H. Duray,
R. O. Jacoby, and A. C. Steere.
1988.
Experimental Lyme arthritis in rats infected with Borrelia burgdorferi.
J. Infect. Dis.
157:842-846[Medline].
|
| 6.
|
Barthold, S. W.,
D. S. Beck,
G. M. Hansen,
G. A. Terwilliger, and K. O. Moody.
1990.
Lyme borreliosis in selected strains and ages of laboratory mice.
J. Infect. Dis.
162:133-138[Medline].
|
| 7.
|
Barthold, S. W.,
D. H. Persing,
A. L. Armstrong, and R. A. Peeples.
1991.
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.
Am. J. Pathol.
139:263-273[Abstract].
|
| 8.
|
Barthold, S. W.
1991.
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice.
J. Infect. Dis.
163:419-420[Medline].
|
| 9.
|
Barthold, S. W.,
C. L. Sidman, and A. L. Smith.
1992.
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.
Am. J. Trop. Med. Hyg.
47:605-613.
|
| 10.
|
Barthold, S. W.,
M. S. de Souza,
J. L. Janotka,
A. L. Smith, and D. H. Persing.
1993.
Chronic Lyme borreliosis in the laboratory mouse.
Am. J. Pathol.
143:959-972[Abstract].
|
| 11.
|
Bergstrom, S.,
V. G. Bundoc, and A. G. Barbour.
1989.
Molecular analysis of linear plasmid-encoded major surface proteins, ospA and ospB, of the Lyme disease spirochete, Borrelia burgdorferi.
Mol. Microbiol.
3:479-486[Medline].
|
| 11a.
| Brown, C. Unpublished data.
|
| 12.
|
Dattwyler, R. J.,
D. J. Volkman,
B. J. Luft,
J. J. Halperin,
J. Thomas, and M. G. Golightly.
1988.
Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.
N. Engl. J. Med.
319:1441-1446[Abstract].
|
| 13.
|
de Souza, M.,
A. L. Smith,
D. S. Beck,
L. J. Kim,
G. M. Hansen, Jr., and S. W. Barthold.
1993.
Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal inoculation.
Infect. Immun.
61:4493-4497[Abstract/Free Full Text].
|
| 14.
|
Gassmann, G. S.,
E. Jacobs,
R. Deutzmann, and U. B. Gobel.
1991.
Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product.
J. Bacteriol.
173:1452-1459[Abstract/Free Full Text].
|
| 15.
|
Johnson, R. C.,
C. Kodner, and M. Russell.
1986.
Passive immunization of hamsters against experimental infection with Borrelia burgdorferi.
Infect. Immun.
53:713-714[Abstract/Free Full Text].
|
| 16.
|
Keane-Myers, A., and S. P. Nickell.
1995.
T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
154:1770-1776[Abstract].
|
| 17.
|
Kenefick, K. B.,
L. C. L. Lim,
J. D. Alder,
J. L. Schmitz,
C. J. Czuprynski, and R. F. Schell.
1993.
Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi.
J. Infect. Dis.
167:1086-1092[Medline].
|
| 18.
|
Matyniak, J., and S. L. Reiner.
1995.
T helper phenotype and genetic susceptibility in experimental Lyme disease.
J. Exp. Med.
181:1251-1254[Abstract/Free Full Text].
|
| 19.
|
Norris, S. J.,
J. K. Howell,
S. A. Garza,
M. S. Ferdows, and A. G. Barbour.
1995.
High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi.
Infect. Immun.
63:2206-2212[Abstract].
|
| 20.
|
Otsuka, T.,
D. Villaret,
T. Yokota,
Y. Takebe,
F. Lee,
A. Arai, and K. Arai.
1987.
Structural analysis of the mouse chromosomal gene encoding interleukin 4 which expresses B cell, T cell and mast cell stimulating activities.
Nucleic Acids Res.
15:333-344[Abstract/Free Full Text].
|
| 21.
|
Pennington, P. M.,
C. D. Allred,
C. S. West,
R. Alvarez, and A. G. Barbour.
1997.
Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease.
Infect. Immun.
65:285-292[Abstract].
|
| 22.
|
Persing, D. H.,
B. J. Rutledge,
P. N. Rys,
D. S. Podzorski,
P. D. Mitchell,
K. D. Reed,
B. Liu,
E. Fikrig, and S. E. Malawista.
1994.
Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients.
J. Infect. Dis.
169:668-672[Medline].
|
| 23.
|
Reiner, S.,
S. Zheng,
D. Corry, and R. Locksley.
1993.
Constructing polycompetitor cDNAs for quantitative PCR.
J. Immunol. Methods
165:37-46[Medline].
|
| 24.
|
Schaible, U. E.,
R. Wallich,
M. D. Kramer,
G. Nerz,
T. Stehle,
C. Museteanu, and M. M. Simon.
1994.
Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B cells but not by T cells alone.
Int. Immunol.
6:671-681[Abstract/Free Full Text].
|
| 25.
|
Shih, C.-M.,
S. R. Telford III,
R. J. Pollack, and A. Spielman.
1993.
Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection.
Infect. Immun.
61:2396-2399[Abstract/Free Full Text].
|
| 26.
|
Steere, A. C.,
R. T. Schoen, and E. Taylor.
1987.
The clinical evolution of Lyme arthritis.
Ann. Intern. Med.
107:725-731.
|
| 27.
|
Steere, A. C.
1989.
Lyme disease.
N. Engl. J. Med.
321:586-596[Abstract].
|
| 28.
|
Steere, A. C.,
E. Dwyer, and R. Winchester.
1990.
Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles.
N. Engl. J. Med.
323:219-225[Abstract].
|
| 29.
|
Yang, L.,
J. H. Weis,
E. Eichwald,
C. P. Kolbert,
D. H. Persing, and J. J. Weis.
1994.
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
Infect. Immun.
62:492-500[Abstract/Free Full Text].
|
Infect Immun, May 1998, p. 2065-2071, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Brown, C. R., Lai, A. Y.-C., Callen, S. T., Blaho, V. A., Hughes, J. M., Mitchell, W. J.
(2008). Adenoviral Delivery of Interleukin-10 Fails To Attenuate Experimental Lyme Disease. Infect. Immun.
76: 5500-5507
[Abstract]
[Full Text]
-
Crandall, H., Dunn, D. M., Ma, Y., Wooten, R. M., Zachary, J. F., Weis, J. H., Weiss, R. B., Weis, J. J.
(2006). Gene Expression Profiling Reveals Unique Pathways Associated with Differential Severity of Lyme Arthritis. J. Immunol.
177: 7930-7942
[Abstract]
[Full Text]
-
Dinser, R, Jendro, M C, Schnarr, S, Zeidler, H
(2005). Antibiotic treatment of Lyme borreliosis: what is the evidence?. Ann Rheum Dis
64: 519-523
[Abstract]
[Full Text]
-
Wang, X., Ma, Y., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J.
(2005). Relative Contributions of Innate and Acquired Host Responses to Bacterial Control and Arthritis Development in Lyme Disease. Infect. Immun.
73: 657-660
[Abstract]
[Full Text]
-
Ray, A., Kumar, D., Shakya, A., Brown, C. R., Cook, J. L., Ray, B. K.
(2004). Serum Amyloid A-Activating Factor-1 (SAF-1) Transgenic Mice Are Prone to Develop a Severe Form of Inflammation-Induced Arthritis. J. Immunol.
173: 4684-4691
[Abstract]
[Full Text]
-
Brown, C. R., Blaho, V. A., Loiacono, C. M.
(2004). Treatment of Mice with the Neutrophil-Depleting Antibody RB6-8C5 Results in Early Development of Experimental Lyme Arthritis via the Recruitment of Gr-1- Polymorphonuclear Leukocyte-Like Cells. Infect. Immun.
72: 4956-4965
[Abstract]
[Full Text]
-
Brown, C. R., Blaho, V. A., Loiacono, C. M.
(2003). Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR2. J. Immunol.
171: 893-901
[Abstract]
[Full Text]
-
Diterich, I., Harter, L., Hassler, D., Wendel, A., Hartung, T.
(2001). Modulation of Cytokine Release in Ex Vivo-Stimulated Blood from Borreliosis Patients. Infect. Immun.
69: 687-694
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(2000). Bone-Marrow Chimeras Reveal Hemopoietic and Nonhemopoietic Control of Resistance to Experimental Lyme Arthritis. J. Immunol.
165: 1446-1452
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(1999). Experimental Lyme Arthritis in the Absence of Interleukin-4 or Gamma Interferon. Infect. Immun.
67: 3329-3333
[Abstract]
[Full Text]
-
Brown, C. R., Reiner, S. L.
(1999). Genetic Control of Experimental Lyme Arthritis in the Absence of Specific Immunity. Infect. Immun.
67: 1967-1973
[Abstract]
[Full Text]